Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Qilu Pharmaceutical Co.
AddedFeb 15, 2024
UpdatedJun 28, 2026
Qilu Pharmaceutical Co.

Qilu Pharmaceutical Co.

Public

Qilu Pharmaceutical: Global manufacturer and marketer of generic drugs and active pharmaceutical ingredients.

HQ
Jinan, Shandong, CN
Founded
1958
Overview
Compare
Employees

Qilu Pharmaceutical Co. is a global manufacturer and marketer of generic drugs and active pharmaceutical ingredients (APIs). The company develops, produces, processes, and sells a wide range of pharmaceutical products, focusing on making high-quality medications accessible worldwide. Their mission is to improve global health by providing affordable and effective pharmaceutical solutions.

Qilu Pharmaceutical has achieved significant milestones in the pharmaceutical industry, establishing a strong presence in international markets. The company's commitment to innovation and quality has earned it a reputable standing among healthcare providers and patients globally.

Qilu Pharmaceutical Co. - Similar Companies

Yantai Dongcheng Pharmaceutical Co logo

Yantai Dongcheng Pharmaceutical Co

dcb-group.com

Sun Pharmaceutical Industries logo

Sun Pharmaceutical Industries

Fuji Pharma Co. logo

Fuji Pharma Co.

Kukje Pharma Co. logo

Kukje Pharma Co.

Zuellig Pharma China logo

Zuellig Pharma China

zuelligpharma.com

Solaris Pharma logo

Solaris Pharma

solaris-pharma.com

Luye Pharma Group logo

Luye Pharma Group

Dexcel Pharma logo

Dexcel Pharma

dexcel.com

Phoenix Pharmahandel logo

Phoenix Pharmahandel

phoenixgroup.eu

Teva Pharmaceutical Industries logo

Teva Pharmaceutical Industries

tevapharm.com

R K Pharma logo

R K Pharma

rkpharmainc.com

Three Rivers Pharmaceuticals logo

Three Rivers Pharmaceuticals

Oryza Pharmaceuticals logo

Oryza Pharmaceuticals

oryzapharma.com

Leading Pharma logo

Leading Pharma

leadingpharma.com

Coeptis Pharmaceuticals logo

Coeptis Pharmaceuticals

Qilu Pharmaceutical Co. - Quick Facts

Who are Qilu Pharmaceutical Co.'s competitors?

Companies similar to Qilu Pharmaceutical Co. include Yantai Dongcheng Pharmaceutical Co, Sun Pharmaceutical Industries, Fuji Pharma Co. and Kukje Pharma Co..

When was Qilu Pharmaceutical Co. founded?

Qilu Pharmaceutical Co. was founded in 1958.

Where is Qilu Pharmaceutical Co.'s headquarters located?

Qilu Pharmaceutical Co.'s headquarters is located in Jinan, Shandong, CN.

How many employees does Qilu Pharmaceutical Co. have?

Qilu Pharmaceutical Co. has 10,000 employees as of Feb 4, 2024.

Qilu Pharmaceutical Co. - Classification

Ownership
  • Public
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • APIs
  • Generic Drugs
Tags
  • Distribution
  • Pharma
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified